Home
About
Technology
- Overview
- Grant Funding
Pipeline
News & Media
Investors
Contact

IR Calendar

Investors

Overview
News / Events
Company Info
Financial Info
Stock Data
- Overview
- Quote
- Charts
- Historical Data
SEC Filings
Governance
Investor Tools

News / Events
Presentations
Overview
Press Releases
IR Calendar
Safe Harbor Statement
Email Alerts

Results of Interim Analysis of Phase 2B Study in Rheumatoid Arthritis

May 21, 2020 • 5:30pm EDT

© 2024 Navidea Biopharmaceuticals, Inc. All Rights Reserved.

linkedin

Privacy Policy Disclaimer Sitemap